Nerve Repair and Regeneration Market by Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), - Global Forecast to 2022
[122 Pages Report] The nerve repair market is expected to reach USD 10.59 million from USD 5.13 billion in 2016, at a CAGR of 12.9%. Nerve repair and regeneration products are used by medical professionals to restore normal function to damaged nerves. Nerve injuries are common in the upper (hand and arm) and lower (leg) extremities. Nerve damage can be caused either due to blunt trauma (such as an impact from a fall or from traction injuries from motor vehicle accidents) or sharp trauma (such as from a direct cut from a knife). Surgical nerve repair involves the exploration of the injured nerve and removal of injured tissue from the nerve endings. In these surgeries, nerve repair and regeneration products are used to restore the normal functioning of nerves. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.
Market Dynamics
Drivers
- High incidence of nerve injuries and growing prevalence of neurological disorder
- Increase in geriatric population and subsequent growth in the prevalence of neurological disorder
- Technological advancement
Restraints
- Lack of awareness
- Dearth of trained professionals
Opportunities
- Emerging markets
- Potential of stem cell therapy in nerve repair and regeneration
Challenges
- Donor side morbidity
- Difficulties in treating large nerve gap
- Stringent regulatory frameworks and time consuming approval process
High incidence of nerve injuries and growing prevalence of neurological disorders drives the global nerve repair and regeneration market
It is estimated that about 250,000 peripheral nerve injuries occur annually in the US alone, which accounts for around 42% of the global peripheral nerve injuries. According to a recent study, around 87% of peripheral nerve injuries are caused due to trauma, while the rest are caused due to tumor- and non-tumor-related surgeries. Surgical manipulation or transection during tissue removal can also cause nerve damage. As the number of such injuries is high, the demand for biomaterials such as nerve conduits, nerve wraps, nerve protectors, and nerve connectors is increasing across the globe. This is a major factor aiding the growth of the market.
The objectives of this study are as follows:
- To define, describe, and forecast the market on the basis of product, application, end user, and region
- To provide detailed information regarding the major factors influencing growth of the market (drivers, opportunities, restrains, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
- To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
- To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies
- To track and analyze competitive developments such as merger and acquisitions, regulatory approvals, product launches and agreement in the market
During this research study, major players operating in the nerve repair and regeneration market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.
To know about the assumptions considered for the study, download the pdf brochure
Key players operating in the nerve repair and regeneration market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (UK), Baxter (US), AxoGen (US), and Stryker (US).
Major Market Developments
- In June 2015, Boston Scientific launched precision novi spinal cord stimulator system in Europe and received CE Mark approval for it
- In January 2016, Polyganics (the Netherlands) signed an agreement with MicroAire Surgical Instruments (US) to distribute its peripheral nerve repair products in the US and Canada
- In January 2017, Abbott Laboratories acquired St. Jude Medical to strengthen its position in the neuromodulation market
- In September 2017, Medtronic (Ireland) received FDA approval Intellis platform spinal cord stimulator (SCS)
- In May 2015, Axogen (US) received FDA approval for Avance nerve graft
Target Audience for this Report:
- Nerve repair and regeneration manufacturers and vendors
- Distributors of nerve repair and regeneration devices
- Market research and consulting companies
- Insurance provider
Scope of the Report:
This report categorizes the market into the following segments:
Nerve Repair and Regeneration Market, by Product
- Neurostimulation and Neuromodulation Devices
- Internal Neurostimulation Devices
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- External Neurostimulation Devices
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Biomaterials
- Nerve Conduit
- Nerve Protectors
- Nerve Wraps
- Nerve Connectors
Nerve Repair and Regeneration Market, by Application
- Neurostimulation and Neuromodulation Surgeries
- Internal Neurostimulation and Neuromodulation Surgeries
- External Neurostimulation and Neuromodulation Surgeries
- Direct Nerve Repair/ Neurorrhaphy
- Epineural Repair
- Perineural Repair
- Group Fascicular Repair
- Nerve Grafting
- Autograft
- Allograft
- Xenograft
- Stem Cell Therapy
Nerve Repair and Regeneration Market, by End User
- Hospitals and clinics
- Ambulatory Surgery Center
Nerve Repair and Regeneration Market, by Region
- North America
- US
- Canada
- Europe
- Asia
- China
- Japan
- India
- Rest of Asia (RoA)
- Rest of the World (RoW)
Critical questions which the report answers
- What are new application areas which the nerve repair and regeneration companies are exploring?
- Which are the key players in the market and how intense is the competition?
Available Customizations:
- Company Information: Detailed company profiles of five or more market players
- Further breakdown of the market into specific countries/regions in Europe, and the Rest of the World
The global nerve repair and regeneration market is expected to reach USD 10.59 billion by 2022 from USD 5.79 billion in 2017, at a CAGR of 12.9%. Nerve repair and regeneration products are used by medical professionals for surgical interventions to restore normal nerve function. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major driving factors for this market.
Based on product, the market is segmented into neurostimulation and neuromodulation devices and biomaterials. Neurostimulation and neuromodulation devices are further categorized into internal and external neurostimulation devices, while the biomaterials segment includes nerve conduits, nerve protectors, nerve wraps, and nerve connectors.
By region, the nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, however, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China and India; large population; growth in the number of hospitals, and increasing neurological disorders in the region are some of the key factors driving the high growth of this regional segment.
Nerve repair and regeneration applications in neurostimulation and neuromodulation surgeries, and direct nerve repair/neurorrhaphy drive the growth of nerve repair and regeneration market
Neurostimulation and Neuromodulation Surgeries
Neuromodulation techniques are significantly gaining acceptance as cost-effective and long-term therapies to treat nerve-related disorders and other diseases. The minimally invasive nature of this technique increases its adaptability; hence, it is considered an outpatient procedure. Moreover, these therapies are reversible, that is, non-destructive, which allows physicians to cease treatment as and when required by removing stimulating devices. Factors such as the complex reimbursement structure in all regions, cost of devices, lack of trained professionals (to carry out these procedures), and the presence of alternative therapies like drugs and electroconvulsive therapy will hamper the growth of this market.
Direct Nerve Repair/Neurorrhaphy
Neurorrhaphy is a primary end-to-end reconnection of the facial nerve stumps. Neurorrhaphy helps to provide the best possible outcome as the anatomy and function of the damaged facial nerve is restored. Neurorrhaphy in head and neck surgery is now most commonly performed during the nerve graft replacement of an injured or resected nerve and during the neural anastomosis of a sensate or functional free tissue flap.
Critical questions the report answers:
- Where will all these developments take the industry in the mid to long term?
- What are the upcoming industry applications for nerve repair and regeneration?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Greater preference of drug therapies over nerve repair and regeneration products is expected to restrain the growth of nerve repair and regeneration market. For the treatment of neurological disorders, the preference for drug therapies is higher among patients. This is because there is limited awareness among patients about the availability of alternative surgical treatments that make use of nerve repair and regeneration devices. Moreover, surgeons in several countries have limited knowledge about the various biomaterials (allografts, autografts, and xenografts) and neuromodulation (sacral nerve stimulation and vagus nerve stimulation) devices used in nerve repair and regeneration. Moreover, lack of skilled and trained professionals is also one of the factor restraing the growth of the market. According to estimates from the American Academy of Neurology, there were 16,366 neurologists in the US in 2012, and this figure is estimated to reach 18,060 by 2025; however, the demand for neurologists in the country is projected to increase from 18,180 in 2012 to 21,440 by 2025. As a result, there will be a shortfall of about 3,400 neurologists (or a 19% drop in the total number of neurologists) in the country by 2025.
Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (UK), Baxter (US), AxoGen (US), and Stryker (US) are the top players in Nerve Repair and Regeneration Market. These companies have a broad product portfolio with comprehensive features and have a strong geographical presence. These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.
Table of Contents
1 Introduction (Page No. - 12)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 15)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Executive Summary (Page No. - 22)
4 Premium Insights (Page No. - 25)
4.1 Nerve Repair and Regeneration Market - Overview
4.2 Asian Market, By Application and Country
4.3 Geographic Snapshot of the Global Market
4.4 Nerve Grafting Market, By Type
5 Market Overview (Page No. - 28)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence of Nerve Injuries
5.2.1.2 Rising Geriatric Population and Subsequent Growth in the Prevalence of Neurological Disorders
5.2.1.3 Technological Advancements
5.2.2 Restraints
5.2.2.1 Greater Preference for Drug Therapies Over Nerve Repair and Regeneration Products
5.2.2.2 Dearth of Trained Professionals
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Potential of Stem Cell Therapy in Nerve Repair and Regeneration
5.2.4 Challenges
5.2.4.1 Donor-Site Morbidity
5.2.4.2 Difficulties in Treating Large Nerve Gaps
5.2.4.3 Stringent Regulatory Frameworks and Time-Consuming Approval Processes
6 Market, By Product (Page No. - 32)
6.1 Introduction
6.2 Neurostimulation and Neuromodulation Devices
6.2.1 Internal Neurostimulation Devices
6.2.1.1 Spinal Cord Stimulation
6.2.1.2 Deep Brain Stimulation
6.2.1.3 Vagus Nerve Stimulation
6.2.1.4 Sacral Nerve Stimulation
6.2.1.5 Gastric Electrical Stimulation
6.2.2 External Neurostimulation Devices
6.2.2.1 Transcutaneous Electrical Nerve Stimulation
6.2.2.2 Transcranial Magnetic Stimulation
6.3 Biomaterials
6.3.1 Nerve Conduits
6.3.2 Nerve Protectors
6.3.3 Nerve Wraps
6.3.4 Nerve Connectors
7 Market, By Application (Page No. - 45)
7.1 Introduction
7.2 Neurostimulation and Neuromodulation Surgeries
7.2.1 Internal Neurostimulation and Neuromodulation Surgeries
7.2.2 External Neurostimulation and Neuromodulation Surgeries
7.3 Direct Nerve Repair/Neurorrhaphy
7.3.1 Epineural Repair
7.3.2 Perineural Repair
7.3.3 Group Fascicular Repair
7.4 Nerve Grafting
7.4.1 Autografts
7.4.2 Allografts
7.4.3 Xenografts
7.5 Stem Cell Therapy
8 Market, By End User (Page No. - 55)
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Surgery Centers
9 Market, By Region (Page No. - 59)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia
9.5 Rest of the World
10 Competitive Landscape (Page No. - 83)
10.1 Introduction
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 Regulatory Approvals
10.3.2 Mergers and Acquisitions
10.3.3 Product Launches
10.3.4 Agreements, Collaboration and Partnerships
11 Company Profiles (Page No. - 87)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 Axogen
11.2 Baxter
11.3 Boston Scientific
11.4 Livanova
11.5 Integra Lifesciences
11.6 Medtronic
11.7 Abbott Laboratories
11.8 Stryker
11.9 Polyganics
11.10 Nuvectra
11.11 Neuropace
11.12 Orthomed
11.13 Nevro
*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 113)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (83 Tables)
Table 1 Nerve Repair and Regeneration Market, By Product, 20152022 (USD Million)
Table 2 Neurostimulation and Neuromodulation Devices Market, By Type, 20152022 (USD Million)
Table 3 Neurostimulation and Neuromodulation Devices Market, By Region, 20152022 (USD Million)
Table 4 Internal Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 5 Internal Neurostimulation Devices Market, By Region, 20152022 (USD Million)
Table 6 Spinal Cord Stimulation Devices Market, By Region, 20152022 (USD Million)
Table 7 Deep Brain Stimulation Devices Market, By Region, 20152022 (USD Million)
Table 8 Vagus Nerve Stimulation Devices Market, By Region, 20152022 (USD Million)
Table 9 Sacral Nerve Stimulation Devices Market, By Region, 20152022 (USD Million)
Table 10 Gastric Electrical Stimulation Devices Market, By Region, 20152022 (USD Million)
Table 11 External Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 12 External Neurostimulation Devices Market, By Region, 20152022 (USD Million)
Table 13 Tens Devices Market, By Region, 20152022 (USD Million)
Table 14 Tms Devices Market, By Region, 20152022 (USD Million)
Table 15 Biomaterials Market, By Type, 20152022 (USD Million)
Table 16 Biomaterials Market, By Region, 20152022 (USD Million)
Table 17 Nerve Conduits Market, By Region, 20152022 (USD Million)
Table 18 Nerve Protectors Market, By Region, 20152022 (USD Million)
Table 19 Nerve Wraps Market, By Region, 20152022 (USD Million)
Table 20 Nerve Connectors Market, By Region, 20152022 (USD Million)
Table 21 Nerve Repair and Regeneration Market, By Application, 20152022 (USD Million)
Table 22 Neurostimulation and Neuromodulation Surgeries Market, By Type, 20152022 (USD Million)
Table 23 Neurostimulation and Neuromodulation Surgeries Market, By Region, 20152022 (USD Million)
Table 24 Internal Neurostimulation and Neuromodulation Surgeries Market, By Region, 20152022 (USD Million)
Table 25 External Neurostimulation and Neuromodulation Surgeries Market, By Region, 20152022 (USD Million)
Table 26 Direct Nerve Repair/Neurorrhaphy Market, By Type, 20152022 (USD Million)
Table 27 Direct Nerve Repair/Neurorrhaphy Market, By Region, 20152022 (USD Million)
Table 28 Epineural Repair Market, By Region, 20152022 (USD Million)
Table 29 Perineural Repair Market, By Region, 20152022 (USD Million)
Table 30 Group Fascicular Repair Market, By Region, 20152022 (USD Million)
Table 31 Nerve Grafting Market, By Type, 20152022 (USD Million)
Table 32 Nerve Grafting Market, By Region, 20152022 (USD Million)
Table 33 Autografts Market, By Region, 20152022 (USD Million)
Table 34 Allografts Market, By Region, 20152022 (USD Million)
Table 35 Xenograft Market, By Region, 20152022 (USD Million)
Table 36 Stem Cell Therapy Market, By Region, 20152022 (USD Million)
Table 37 Nerve Repair and Regeneration Market Size, By End User, 20152022 (USD Million)
Table 38 Market for Hospitals & Clinics, By Region, 20152022 (USD Million)
Table 39 Market for Ambulatory Surgery Centers, By Region, 20152022 (USD Million)
Table 40 Market, By Region, 20152022 (USD Million)
Table 41 North America: Nerve Repair and Regeneration Market, By Country, 20152022 (USD Million)
Table 42 North America: Market, By Product, 20152022 (USD Million)
Table 43 North America: Neurostimulation and Neuromodulation Devices Market, By Type, 20152022 (USD Million)
Table 44 North America: Internal Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 45 North America: External Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 46 North America: Biomaterials Market, By Type, 20152022 (USD Million)
Table 47 North America: Market, By Application, 20152022 (USD Million)
Table 48 North America: Market, By End User, 20152022 (USD Million)
Table 49 US: Market, By End User, 20152022 (USD Million)
Table 50 Neurological Conditions in Canada
Table 51 Canada: Nerve Repair and Regeneration Market, By End User, 20152022 (USD Million)
Table 52 Europe: Market, By Country, 20152022 (USD Million)
Table 53 Europe: Market, By Product, 20152022 (USD Million)
Table 54 Europe: Neurostimulation and Neuromodulation Devices Market, By Type, 20152022 (USD Million)
Table 55 Europe: Internal Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 56 North America: External Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 57 Europe: Biomaterials Market, By Type, 20152022 (USD Million)
Table 58 Europe: Market, By Application, 20152022 (USD Million)
Table 59 Europe: Market, By End User, 20152022 (USD Million)
Table 60 Asia: Nerve Repair and Regeneration Market, By Country, 20152022 (USD Million)
Table 61 Asia: Market, By Product, 20152022 (USD Million)
Table 62 Asia: Neurostimulation and Neuromodulation Devices Market, By Type, 20152022 (USD Million)
Table 63 Asia: Internal Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 64 Asia: External Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 65 Asia: Biomaterials Market, By Type, 20152022 (USD Million)
Table 66 Asia: Market, By Application, 20152022 (USD Million)
Table 67 Asia: Market, By End User, 20152022 (USD Million)
Table 68 China: Market, By End User, 20152022 (USD Million)
Table 69 Japan: Market, By End User, 20152022 (USD Million)
Table 70 India: Nerve Repair and Regeneration Market, By End User, 20152022 (USD Million)
Table 71 RoA: Market, By End User, 20152022 (USD Million)
Table 72 RoW: Market, By Product, 20152022 (USD Million)
Table 73 RoW: Neurostimulation and Neuromodulation Devices Market, By Type, 20152022 (USD Million)
Table 74 RoW: Internal Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 75 RoW: External Neurostimulation Devices Market, By Type, 20152022 (USD Million)
Table 76 RoW: Biomaterials Market, By Type, 20152022 (USD Million)
Table 77 RoW: Market, By Application, 20152022 (USD Million)
Table 78 RoW: Market, By End User, 20152022 (USD Million)
Table 79 Growth Strategy Matrix, 20142017
Table 80 Regulatory Approval, 20142017
Table 81 Mergers and Acquisitions, 20142017
Table 82 Product Launches, 20142017
Table 83 Agreements, Collaboration, and Partnerships, 20142017
List of Figures (31 Figures)
Figure 1 Research Design: Nerve Repair & Regeneration Market
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Nerve Repair and Regeneration Market Size, By Product, 2017 vs 2022 (USD Billion)
Figure 7 Market Size, By Application, 2017 vs 2022 (USD Billion)
Figure 8 Market Size, By End User, 2017 vs 2022 (USD Billion)
Figure 9 Market Size, By Region, 2017 vs 2022 (USD Billion)
Figure 10 High Incidence of Nerve Injuries and Growing Prevalence of Neurological Disorders to Drive the Market Growth
Figure 11 Neurostimulation and Neuromodulation Surgeries to Dominate the Asian Market in 2017
Figure 12 Asia to Register the Highest CAGR During the Forecast Period
Figure 13 Xenografts Will Continue to Register Highest Growth Rate During Forecast Period
Figure 14 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Neurostimulation and Neuromodulation Devices, the Largest Product Segment in the Market
Figure 16 Neurostimulation and Neuromodulation Surgeries Segment to Dominate the Market During the Forecast Period
Figure 17 Hospitals & Clinics Segment to Dominate the Market During the Forecast Period
Figure 18 North America to Dominate the Market in 2017
Figure 19 Asia to Register the Highest CAGR in the Nerve Repair and Regeneration Market During the Forecast Period
Figure 20 North America: Market Snapshot
Figure 21 Asia: Market Snapshot
Figure 22 Global Market: Market Share (2016)
Figure 23 Axogen: Company Snapshot (2016)
Figure 24 Baxter: Company Snapshot (2016)
Figure 25 Boston Scientific: Company Snapshot (2016)
Figure 26 Livanova: Company Snapshot (2016)
Figure 27 Integra Lifesciences: Company Snapshot (2016)
Figure 28 Medtronic: Company Snapshot (2016)
Figure 29 Abbott Laboratories: Company Snapshot (2016)
Figure 30 Stryker: Company Snapshot (2016)
Figure 31 Nervo: Company Snapshot (2016)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Nerve Repair and Regeneration Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Nerve Repair and Regeneration Market